NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of NAPCO Security Technologies, Inc. (NASDAQ: NSSC) resulting from allegations that NAPCO may have issued materially misleading business information to the investing public.

NEW ORLEANS, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 24, 2025 to file lead plaintiff applications in securities class action lawsuits against Transocean Ltd. (the “Company”) (NYSE: RIG), if they purchased the Company's securities between May 1, 2023 and September 2, 2024, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Southern District of New York.

NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, both dates inclusive (the “Class Period”), of the important March 14, 2025 lead plaintiff deadline.

NEW ORLEANS, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 31, 2025 to file lead plaintiff applications in a securities class action lawsuit against Integral Ad Science Holding Corp. (the “Company”) (NasdaqGS: IAS), if they purchased the Company's shares between March 2, 2023 and February 27, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 24, 2025 to file lead plaintiff applications in a securities class action lawsuit against Crocs, Inc. (NasdaqGS: CROX), if they purchased the Company's shares between November 3, 2022, and October 28 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Delaware.

NEW ORLEANS, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 18, 2025 to file lead plaintiff applications in a securities class action lawsuit against Innovative Industrial Properties, Inc. (NYSE: IIPR), if they purchased the Company's securities between February 27, 2024 and December 19, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Maryland.

NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the “Class Period”), of the important March 25, 2025 lead plaintiff deadline.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=128877&wire=1 or contact Joseph E. Levi, Esq.

NEW ORLEANS, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 18, 2025 to file lead plaintiff applications in a securities class action lawsuit against FTAI Aviation Ltd. (the “Company”) (NasdaqGS: FTAI), if they purchased the Company's securities between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 14, 2025 to file lead plaintiff applications in a securities class action lawsuit against Pacira BioSciences, Inc. (the “Company”) (NasdaqGS: PCRX), if they purchased the Company's securities between August 2, 2023 and August 8, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.

NEW ORLEANS, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 25, 2025 to file lead plaintiff applications in a securities class action lawsuit against Nextracker Inc. (the “Company”) (NasdaqGS: NXT), if they purchased the Company's shares between February 1, 2024 and August 1, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

NEW ORLEANS, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 21, 2025 to file lead plaintiff applications in a securities class action lawsuit against Capri Holdings Limited (the “Company”) (NYSE: CPRI), if they purchased the Company's shares and/or sold Capri puts between August 10, 2023 and October 24, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Delaware.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Rosen Law Firm PA WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Nextracker Inc. (NASDAQ:NXT) between February 1, 2024 and August 1, 2024, both dates inclusive (the "Class Period"), of the important February 25, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nextracker common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Diodes Incorporated (NASDAQ:DIOD ) Q4 2024 Earnings Conference Call February 11, 2025 5:00 PM ET Company Participants Leanne Sievers - Shelton Group, IR Gary Yu - President & Director Brett Whitmire - CFO Emily Yang - SVP, Worldwide Sales & Marketing Conference Call Participants David Williams - The Benchmark Company William Stein - Truist Securities, Inc. Operator Good afternoon, and welcome to Diodes Inc. Fourth Quarter and Fiscal 2024 Financial Results Conference Call. [Operator Instructions].

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Monolithic Power Systems Inc. (NASDAQ:MPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=128875&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=128876&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=128874&wire=1 or contact Joseph E. Levi, Esq.

Sensata Technologies Holding PLC (NYSE:ST ) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Company Participants James Entwistle - Senior Director of Investor Relations Stephan von Schuckmann - Chief Executive Officer Brian Roberts - Chief Financial Officer Conference Call Participants Joe Giordano - TD Cowen Amit Daryanani - Evercore Mark Delaney - Goldman Sachs Christopher Glynn - Oppenheimer Luke Junk - Baird Guy Hardwick - Freedom Capital Markets Samik Chatterjee - J.P. Morgan Zach Walljasper - UBS Operator Good afternoon, and welcome to the Sensata Technologies' Fourth Quarter and Full-Year 2024 Earnings Call.

Atomera Incorporated (NASDAQ:ATOM ) Q4 2024 Earnings Conference Call February 11, 2024 5:00 PM ET Company Participants Mike Bishop - IR Scott Bibaud - President and CEO Frank Laurencio - CFO Conference Call Participants Richard Shannon - Craig Hallum Cody Acree - Benchmark Mike Bishop Hello, everyone and welcome to Atomera's Fourth Quarter and Fiscal Year 2024 Update Call. I'd like to remind everyone that this call and webinar are being recorded, and a replay will be available on Atomera's IR website for one year.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the common stock of Neumora Therapeutics, Inc.(NASDAQ:NMRA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Offering Documents") issued in connection with Neumora's September 2023 initial public offering (the "IPO"). If you wish to serve as lead plaintiff, you must move the Court no later than April 7, 2025.